Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Prepaid Assets: 2021-2024

Historic Prepaid Assets for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Dec 2024 value amounting to $12.5 million.

  • Amylyx Pharmaceuticals' Prepaid Assets rose 1.36% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 1.36%. This contributed to the annual value of $12.5 million for FY2024, which is 16.39% down from last year.
  • Per Amylyx Pharmaceuticals' latest filing, its Prepaid Assets stood at $12.5 million for FY2024, which was down 16.39% from $14.9 million recorded in FY2023.
  • In the past 5 years, Amylyx Pharmaceuticals' Prepaid Assets registered a high of $14.9 million during FY2023, and its lowest value of $5.4 million during FY2021.
  • For the 3-year period, Amylyx Pharmaceuticals' Prepaid Assets averaged around $12.5 million, with its median value being $12.5 million (2024).
  • Per our database at Business Quant, Amylyx Pharmaceuticals' Prepaid Assets skyrocketed by 87.56% in 2022 and then fell by 16.39% in 2024.
  • Amylyx Pharmaceuticals' Prepaid Assets (Yearly) stood at $5.4 million in 2021, then skyrocketed by 87.56% to $10.1 million in 2022, then surged by 47.64% to $14.9 million in 2023, then dropped by 16.39% to $12.5 million in 2024.